Skip to main content
Premium Trial:

Request an Annual Quote

Twist Bioscience Providing Antibody Optimization to Pandion Therapeutics for Drug Development

NEW YORK (GenomeWeb) – Twist Bioscience and Pandion Therapeutics plan to use Twist's antibody optimization platform to develop therapeutics for autoimmune and inflammatory disease, the companies said today.

The firms did not disclose financial details of the agreement.

Twist "has a highly differentiated capability to optimize antibodies for many attributes including affinity, expression, solubility, half-life, immunogenicity, druggability, and processability," Anthony Coyle, co-founder and CEO of Pandion, said in a statement.

The antibody optimization platform makes use of Twist's high-throughput oligonucleotide synthesis technology to generate an antibody library.

Pandion is a Cambridge, Massachusetts-based biotech company that was founded in 2017 and is focused on developing a pipeline of antibody therapeutics.

Last week, Twist announced a separate strategic collaboration with LakePharma, a contract research, development and manufacturing organization (CRDMO) for biologics, to offer antibody discovery and development services to pharmaceutical and biotech customers.

Under the terms of that deal, LakePharma will offer Twist's antibody optimization platform as a service to its customers while Twist will have access to LakePharma's discovery and development services.

Aside from its collaborations with Pandion and LakePharma, Twist is also working with Vanderbilt University Medical Center to discover and design antibody therapeutics against potential pandemics such as Zika virus.

Early this year, Twist CEO Emily Leproust said that drug discovery, harnessing its ability to make large antibody libraries, would be a focus of the company.

The Scan

Long COVID-19 Susceptibility Clues Contained in Blood Plasma Proteome

A longitudinal study in eBioMedicine found weeks-long blood plasma proteome shifts after SARS-CoV-2 infection, along with proteomic signatures that appeared to coincide with long Covid risk.

Tibetan Study Finds Adaptive Variant Influencing Skin Pigmentation

With a combination of phenotyping and genetic data, researchers document at PNAS a Tibetan-enriched enhancer variant influencing melanin synthesis and ultraviolet light response.

Domestication Linked to Nervous System Genes in Inbred Mouse Strains

Researchers highlighted more than 300 positively selected genes in domesticated mice, including genes linked to nervous system function or behavior in Genome Biology.

ALS Genetic Testing May Be Informative Across Age Ranges, Study Finds

Researchers in the journal Brain identified clinically actionable variants in a significant subset of older ALS patients, prompting them to point to the potential benefits of broader test use.